Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

EpiStem to conduct preclinical testing for Callisto's guanilib

May 16, 2006

Anti-hepatitis C activity of NIM-811 demonstrated in vivo

May 16, 2006

Preclinical and clinical update on NeuGene antisense compound for HCV

May 12, 2006

Second phase III trial begins for pancreatic enzyme product EUR-1008

May 12, 2006

Tranzyme completes phase I study of ghrelin receptor agonist TZP-101

May 12, 2006

Use of alvimopan for the gastrointestinal adverse effects of opioids studied

May 10, 2006

Clevudine effective in hepatitis B patients treated for 1 year

May 9, 2006

Study results detail entecavir efficacy in hepatitis B

May 9, 2006

Recent patents disclose novel therapeutic agents for gastrointestinal disorders

May 8, 2006

XTL-2125 studied for chronic hepatitis C in new phase I trial

May 5, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...